FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1696210500> ?p ?o ?g. }

• W1696210500 endingPage "55" @default.
• W1696210500 startingPage "41" @default.
• W1696210500 abstract "Activating mutations in KRAS are prevalent in cancer, but therapies targeted to oncogenic RAS have been ineffective to date. These results argue that targeting downstream effectors of RAS will be an alternative route for blocking RAS-driven oncogenic pathways. We and others have shown that oncogenic RAS activates the NF-κB transcription factor pathway and that KRAS-induced lung tumorigenesis is suppressed by expression of a degradation-resistant form of the IκBα inhibitor or by genetic deletion of IKKβ or the RELA/p65 subunit of NF-κB. Here, genetic and pharmacological approaches were utilized to inactivate IKK in human primary lung epithelial cells transformed by KRAS, as well as KRAS mutant lung cancer cell lines. Administration of the highly specific IKKβ inhibitor Compound A (CmpdA) led to NF-κB inhibition in different KRAS mutant lung cells and siRNA-mediated knockdown of IKKα or IKKβ reduced activity of the NF-κB canonical pathway. Next, we determined that both IKKα and IKKβ contribute to oncogenic properties of KRAS mutant lung cells, particularly when p53 activity is disrupted. Based on these results, CmpdA was tested for potential therapeutic intervention in the Kras-induced lung cancer mouse model (LSL-Kras (G12D)) combined with loss of p53 (LSL-Kras (G12D)/p53 (fl/fl)). CmpdA treatment was well tolerated and mice treated with this IKKβ inhibitor presented smaller and lower grade tumors than mice treated with placebo. Additionally, IKKβ inhibition reduced inflammation and angiogenesis. These results support the concept of targeting IKK as a therapeutic approach for oncogenic RAS-driven tumors with altered p53 activity." @default.
• W1696210500 created "2016-06-24" @default.
• W1696210500 creator A5022505227 @default.
• W1696210500 creator A5034236608 @default.
• W1696210500 creator A5071347161 @default.
• W1696210500 creator A5074322188 @default.
• W1696210500 date "2014-04-21" @default.
• W1696210500 modified "2023-09-26" @default.
• W1696210500 title "IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity" @default.
• W1696210500 cites W1581923494 @default.
• W1696210500 cites W1692939660 @default.
• W1696210500 cites W1965626427 @default.
• W1696210500 cites W1968730445 @default.
• W1696210500 cites W1971971854 @default.
• W1696210500 cites W1975359970 @default.
• W1696210500 cites W1981912182 @default.
• W1696210500 cites W1984795762 @default.
• W1696210500 cites W1985538305 @default.
• W1696210500 cites W1988924112 @default.
• W1696210500 cites W1990974592 @default.
• W1696210500 cites W1991868611 @default.
• W1696210500 cites W1994772304 @default.
• W1696210500 cites W1999177172 @default.
• W1696210500 cites W1999851814 @default.
• W1696210500 cites W2000896073 @default.
• W1696210500 cites W2001999652 @default.
• W1696210500 cites W2004216400 @default.
• W1696210500 cites W2006019980 @default.
• W1696210500 cites W2007251599 @default.
• W1696210500 cites W2020045401 @default.
• W1696210500 cites W2029000257 @default.
• W1696210500 cites W2032019019 @default.
• W1696210500 cites W2041255253 @default.
• W1696210500 cites W2041600831 @default.
• W1696210500 cites W2046180063 @default.
• W1696210500 cites W2052908553 @default.
• W1696210500 cites W2059457766 @default.
• W1696210500 cites W2059983531 @default.
• W1696210500 cites W2063270450 @default.
• W1696210500 cites W2063382154 @default.
• W1696210500 cites W2072805739 @default.
• W1696210500 cites W2084336363 @default.
• W1696210500 cites W2090251628 @default.
• W1696210500 cites W2091814594 @default.
• W1696210500 cites W2097152766 @default.
• W1696210500 cites W2111274419 @default.
• W1696210500 cites W2113764608 @default.
• W1696210500 cites W2116666113 @default.
• W1696210500 cites W2116934284 @default.
• W1696210500 cites W2117412547 @default.
• W1696210500 cites W2120741863 @default.
• W1696210500 cites W2121937165 @default.
• W1696210500 cites W2123879591 @default.
• W1696210500 cites W2125194042 @default.
• W1696210500 cites W2128059540 @default.
• W1696210500 cites W2136940817 @default.
• W1696210500 cites W2138934663 @default.
• W1696210500 cites W2139532459 @default.
• W1696210500 cites W2142277736 @default.
• W1696210500 cites W2149122802 @default.
• W1696210500 cites W2155228605 @default.
• W1696210500 cites W2155489291 @default.
• W1696210500 cites W2158734599 @default.
• W1696210500 cites W2160444874 @default.
• W1696210500 cites W2165575701 @default.
• W1696210500 cites W2172010722 @default.
• W1696210500 cites W2783677708 @default.
• W1696210500 doi "https://doi.org/10.18632/genesandcancer.5" @default.
• W1696210500 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4063255" @default.
• W1696210500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24955217" @default.
• W1696210500 hasPublicationYear "2014" @default.
• W1696210500 type Work @default.
• W1696210500 sameAs 1696210500 @default.
• W1696210500 citedByCount "30" @default.
• W1696210500 countsByYear W16962105002014 @default.
• W1696210500 countsByYear W16962105002015 @default.
• W1696210500 countsByYear W16962105002016 @default.
• W1696210500 countsByYear W16962105002017 @default.
• W1696210500 countsByYear W16962105002018 @default.
• W1696210500 countsByYear W16962105002019 @default.
• W1696210500 countsByYear W16962105002020 @default.
• W1696210500 countsByYear W16962105002021 @default.
• W1696210500 countsByYear W16962105002022 @default.
• W1696210500 crossrefType "journal-article" @default.
• W1696210500 hasAuthorship W1696210500A5022505227 @default.
• W1696210500 hasAuthorship W1696210500A5034236608 @default.
• W1696210500 hasAuthorship W1696210500A5071347161 @default.
• W1696210500 hasAuthorship W1696210500A5074322188 @default.
• W1696210500 hasBestOaLocation W16962105001 @default.
• W1696210500 hasConcept C100175707 @default.
• W1696210500 hasConcept C121608353 @default.
• W1696210500 hasConcept C126322002 @default.
• W1696210500 hasConcept C143998085 @default.
• W1696210500 hasConcept C173396325 @default.
• W1696210500 hasConcept C203014093 @default.
• W1696210500 hasConcept C2776256026 @default.
• W1696210500 hasConcept C2776914184 @default.
• W1696210500 hasConcept C2777730290 @default.

• next